首页 > 最新文献

Iranian Journal of Otorhinolaryngology最新文献

英文 中文
Agreement between HRCT Imaging and Intraoperative Measurements in Predicting Stapedotomy Prosthesis Length in Otosclerosis Patients. HRCT成像与术中测量预测耳硬化患者镫骨切开术假体长度的一致性。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.81759.3749
Mohamad Reza Afzalzadeh, Farzaneh Khoroushi, Abolfazl Zanjani Tabasi, Yazdan Gholami Chenaran, Mohsen Rajati, Hassan Mehrad-Majd

Introduction: This study aimed to evaluate the accuracy of preoperative high-resolution computed tomography (HRCT) imaging in measuring the distance from the long process of the incus to the footplate and its potential for predicting the optimal prosthesis length required for stapedotomy in patients with otosclerosis.

Materials and methods: This cross-sectional study included fifty patients scheduled for primary stapedotomy. A radiologist obtained and reconstructed preoperative HRCT scans of the temporal bone to measure the distance from the long process of the incus to the oval window in both axial and coronal views. These HRCT-derived measurements were then compared with intraoperative measurements performed by an otolaryngologist. The agreement between the two methods was assessed using correlation and Bland-Altman analysis.

Results: The mean distances measured by HRCT and intraoperatively were 4.15mm and 4.27mm, respectively. A strong and statistically significant correlation (r=0.928, P<0.001) was observed between the two approaches, indicating a robust association. The Bland-Altman analysis revealed a mean bias of 0.11±0.07mm, with limits of agreement (LoAs) ranging from -0.02 to 0.26 mm, and no points exceeding the 95% LoAs. The maximum potential error between the two measurement methods was 0.28mm, suggesting that HRCT imaging can reliably predict prosthesis length. In a stratified analysis based on the surgical distance (≤4 mm [N=11], 4.25mm [N=25], ≥4.5mm [N=13]), good agreement was maintained in the Bland-Altman analysis.

Conclusion: Preoperative HRCT imaging may be a valuable tool for accurately predicting the required prosthesis length prior to stapedotomy in otosclerosis patients.

前言:本研究旨在评估术前高分辨率计算机断层扫描(HRCT)成像在测量从砧骨到足踏板的距离方面的准确性,以及它在预测耳硬化患者镫骨切除术所需的最佳假体长度方面的潜力。材料和方法:本横断面研究包括50例预定进行初级镫骨切除术的患者。放射科医生获得并重建术前颞骨HRCT扫描,以测量轴位和冠状位上从砧骨长突到卵圆窗的距离。然后将这些hrct测量结果与耳鼻喉科医生进行的术中测量结果进行比较。使用相关性和Bland-Altman分析来评估两种方法之间的一致性。结果:HRCT和术中测量的平均距离分别为4.15mm和4.27mm。结论:术前HRCT成像可能是耳硬化患者镫骨切除术前准确预测所需假体长度的有价值的工具。
{"title":"Agreement between HRCT Imaging and Intraoperative Measurements in Predicting Stapedotomy Prosthesis Length in Otosclerosis Patients.","authors":"Mohamad Reza Afzalzadeh, Farzaneh Khoroushi, Abolfazl Zanjani Tabasi, Yazdan Gholami Chenaran, Mohsen Rajati, Hassan Mehrad-Majd","doi":"10.22038/ijorl.2025.81759.3749","DOIUrl":"10.22038/ijorl.2025.81759.3749","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to evaluate the accuracy of preoperative high-resolution computed tomography (HRCT) imaging in measuring the distance from the long process of the incus to the footplate and its potential for predicting the optimal prosthesis length required for stapedotomy in patients with otosclerosis.</p><p><strong>Materials and methods: </strong>This cross-sectional study included fifty patients scheduled for primary stapedotomy. A radiologist obtained and reconstructed preoperative HRCT scans of the temporal bone to measure the distance from the long process of the incus to the oval window in both axial and coronal views. These HRCT-derived measurements were then compared with intraoperative measurements performed by an otolaryngologist. The agreement between the two methods was assessed using correlation and Bland-Altman analysis.</p><p><strong>Results: </strong>The mean distances measured by HRCT and intraoperatively were 4.15mm and 4.27mm, respectively. A strong and statistically significant correlation (r=0.928, P<0.001) was observed between the two approaches, indicating a robust association. The Bland-Altman analysis revealed a mean bias of 0.11±0.07mm, with limits of agreement (LoAs) ranging from -0.02 to 0.26 mm, and no points exceeding the 95% LoAs. The maximum potential error between the two measurement methods was 0.28mm, suggesting that HRCT imaging can reliably predict prosthesis length. In a stratified analysis based on the surgical distance (≤4 mm [N=11], 4.25mm [N=25], ≥4.5mm [N=13]), good agreement was maintained in the Bland-Altman analysis.</p><p><strong>Conclusion: </strong>Preoperative HRCT imaging may be a valuable tool for accurately predicting the required prosthesis length prior to stapedotomy in otosclerosis patients.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 4","pages":"205-211"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144821389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term Effects of Nortriptyline on Sleep Parameters for Residual OSA after UPPP. 去甲替林对upppp后残余OSA患者睡眠参数的短期影响。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.87813.3947
Reza Hosseini, Pedram Borghei, Amin Amali, Reihaneh Heidari, Reza Erfanian

Introduction: Uvulopalatopharyngoplasty (UPPP) surgery, though helpful, may not always achieve optimal results for obstructive sleep apnea (OSA). This prospective, uncontrolled trial investigates the potential of nortriptyline in improving symptoms and sleep parameters in OSA patients who have previously undergone UPPP.

Materials and methods: This single-center study evaluated the effects of nortriptyline in 24 OSA patients who had undergone UPPP surgery one year prior. Participants underwent a type IV sleep study one night before starting nortriptyline, and one month after treatment. The study employed the Stanford Subjective Snoring Scale (SSSS) and the Epworth Sleepiness Scale (ESS) to evaluate subjective reports of snoring and daytime sleepiness.

Results: The Apnea-Hypopnea Index (AHI) significantly decreased from 16.8 to 11.4 events/hour (p-value = 0.02, effect size = 0.5). Mean oxygen saturation significantly increased from 94.1% to 95.4% (p-value = 0.016, effect size = 0.6). Time spent below 90% oxygen saturation significantly decreased from 7.2% to 4.8% (p-value = 0.007, effect size = 0.73). ESS significantly decreased from 9.6 to 7.2 (p-value < 0.001, effect size = 0.89). SSSS significantly decreased from 7.1 to 3.1 (p-value = 0.002, effect size = 0.90). Minor side effects were monitored; one participant developed excessive sleepiness, and another participant reported heart palpitations.

Conclusion: This trial suggests that nortriptyline may be a promising treatment option for improving residual sleep apnea in patients who have already undergone UPPP but still experience symptoms. Further research is needed to confirm these initial results. Trial registration number: IRCT20230614058482N1.

简介:Uvulopalatopharyngoplasty (UPPP)手术,虽然有帮助,但可能并不总是达到最佳效果阻塞性睡眠呼吸暂停(OSA)。这项前瞻性、非对照试验调查了去甲替林在改善先前接受过UPPP的OSA患者的症状和睡眠参数方面的潜力。材料和方法:本单中心研究评估了去甲替林对24例一年前接受过upppp手术的OSA患者的影响。参与者在开始使用去甲替林前一晚和治疗后一个月进行了IV型睡眠研究。该研究采用斯坦福主观打鼾量表(SSSS)和Epworth嗜睡量表(ESS)来评估打鼾和白天嗜睡的主观报告。结果:呼吸暂停低通气指数(AHI)由16.8次/小时显著降低至11.4次/小时(p值= 0.02,效应值= 0.5)。平均血氧饱和度从94.1%提高到95.4% (p值= 0.016,效应值= 0.6)。低于90%氧饱和度的时间从7.2%显著减少到4.8% (p值= 0.007,效应值= 0.73)。ESS从9.6显著降低到7.2 (p值< 0.001,效应值= 0.89)。SSSS从7.1显著降低到3.1 (p值= 0.002,效应值= 0.90)。监测轻微副作用;一名参与者出现过度嗜睡,另一名参与者报告心悸。结论:该试验表明,去甲替林可能是一种有希望的治疗选择,可以改善已经接受过UPPP但仍有症状的患者的残留睡眠呼吸暂停。需要进一步的研究来证实这些初步结果。试验注册号:IRCT20230614058482N1。
{"title":"Short-term Effects of Nortriptyline on Sleep Parameters for Residual OSA after UPPP.","authors":"Reza Hosseini, Pedram Borghei, Amin Amali, Reihaneh Heidari, Reza Erfanian","doi":"10.22038/ijorl.2025.87813.3947","DOIUrl":"10.22038/ijorl.2025.87813.3947","url":null,"abstract":"<p><strong>Introduction: </strong>Uvulopalatopharyngoplasty (UPPP) surgery, though helpful, may not always achieve optimal results for obstructive sleep apnea (OSA). This prospective, uncontrolled trial investigates the potential of nortriptyline in improving symptoms and sleep parameters in OSA patients who have previously undergone UPPP.</p><p><strong>Materials and methods: </strong>This single-center study evaluated the effects of nortriptyline in 24 OSA patients who had undergone UPPP surgery one year prior. Participants underwent a type IV sleep study one night before starting nortriptyline, and one month after treatment. The study employed the Stanford Subjective Snoring Scale (SSSS) and the Epworth Sleepiness Scale (ESS) to evaluate subjective reports of snoring and daytime sleepiness.</p><p><strong>Results: </strong>The Apnea-Hypopnea Index (AHI) significantly decreased from 16.8 to 11.4 events/hour (p-value = 0.02, effect size = 0.5). Mean oxygen saturation significantly increased from 94.1% to 95.4% (p-value = 0.016, effect size = 0.6). Time spent below 90% oxygen saturation significantly decreased from 7.2% to 4.8% (p-value = 0.007, effect size = 0.73). ESS significantly decreased from 9.6 to 7.2 (p-value < 0.001, effect size = 0.89). SSSS significantly decreased from 7.1 to 3.1 (p-value = 0.002, effect size = 0.90). Minor side effects were monitored; one participant developed excessive sleepiness, and another participant reported heart palpitations.</p><p><strong>Conclusion: </strong>This trial suggests that nortriptyline may be a promising treatment option for improving residual sleep apnea in patients who have already undergone UPPP but still experience symptoms. Further research is needed to confirm these initial results. Trial registration number: IRCT20230614058482N1.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 5","pages":"233-240"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrasphenoidal Internal Carotid Artery Aneurysm: Rare Cause of Recurrent Epistaxis. 颈内动脉瘤:复发性鼻出血的罕见原因。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.82770.3788
Harneet Narula, Aditi Vohra, Gavinder Singh Bindra, Amit Jain

Introduction: Epistaxis is a common Otorhinolaryngological condition that is usually self-limiting and rarely requires imaging and intervention. Intrasinus Internal Carotid Artery aneurysm presenting with epistaxis is extremely rare.

Case report: We report a case of a 57- year old male presenting with recurrent episodes of epistaxis. Contrast-enhanced Computed Tomography of the Paranasal Sinuses and Magnetic Resonance Imaging were performed, which showed a focal defect in the posterolateral wall of the sphenoid sinus through which an aneurysm from the cavernous segment of the Internal Carotid artery was seen herniating into the sinus with an associated hematoma.

Conclusion: Non-traumatic Internal carotid artery Intrasphenoidal aneurysms are infrequent causes of recurrent epistaxis. They can mimic malignant or inflammatory sinus masses, which can lead to inadvertent biopsy; hence, they should be ruled out by radiological investigation to ensure timely diagnosis and management.

简介:鼻出血是一种常见的耳鼻喉科疾病,通常是自限性的,很少需要成像和干预。以鼻出血为表现的颈内动脉瘤是极为罕见的。病例报告:我们报告了一个57岁的男性,表现为反复发作的鼻出血。鼻窦增强ct和磁共振成像显示蝶窦后外侧壁有局灶性缺损,颈内动脉海绵状段的动脉瘤通过该缺损疝入鼻窦并伴有血肿。结论:非外伤性颈内动脉瘤是引起复发性鼻出血的罕见原因。它们可以模拟恶性或炎症性窦肿块,这可能导致无意的活检;因此,应通过放射检查排除,以确保及时诊断和治疗。
{"title":"Intrasphenoidal Internal Carotid Artery Aneurysm: Rare Cause of Recurrent Epistaxis.","authors":"Harneet Narula, Aditi Vohra, Gavinder Singh Bindra, Amit Jain","doi":"10.22038/ijorl.2025.82770.3788","DOIUrl":"10.22038/ijorl.2025.82770.3788","url":null,"abstract":"<p><strong>Introduction: </strong>Epistaxis is a common Otorhinolaryngological condition that is usually self-limiting and rarely requires imaging and intervention. Intrasinus Internal Carotid Artery aneurysm presenting with epistaxis is extremely rare.</p><p><strong>Case report: </strong>We report a case of a 57- year old male presenting with recurrent episodes of epistaxis. Contrast-enhanced Computed Tomography of the Paranasal Sinuses and Magnetic Resonance Imaging were performed, which showed a focal defect in the posterolateral wall of the sphenoid sinus through which an aneurysm from the cavernous segment of the Internal Carotid artery was seen herniating into the sinus with an associated hematoma.</p><p><strong>Conclusion: </strong>Non-traumatic Internal carotid artery Intrasphenoidal aneurysms are infrequent causes of recurrent epistaxis. They can mimic malignant or inflammatory sinus masses, which can lead to inadvertent biopsy; hence, they should be ruled out by radiological investigation to ensure timely diagnosis and management.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 5","pages":"281-285"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Epirubicin Be Used in Laryngology Practice Like Mitomycin? An Experimental and Pioneering Study. 表柔比星能像丝裂霉素一样应用于喉科吗?一项实验性和开创性的研究。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.87024.3938
Erdem Koroglu, Selahattin Genc, Serdar Baser, Ferit Bayakır, Ahmet Tugrul Eruyar, Busra Yaprak Bayrak

Introduction: Epirubicin and mitomycin-C share similar mechanisms of action, with both exhibiting antiproliferative effects by inhibiting DNA and protein synthesis. While the efficacy of mitomycin-C in laryngology is well established, this study aims to investigate whether epirubicin can produce comparable clinical outcomes in this field.

Materials and methods: Ten rabbits were included in this experimental study. A thermal injury was created at the posterior commissure using a conchal probe. Following the injury, one group was treated with mitomycin-C, while the other received epirubicin. After a six-week post-treatment period, the rabbits were euthanized, and both macroscopic and microscopic evaluations were performed to assess stenosis, scarring, granulation tissue, necrosis, and ulceration. Two pathologists, blinded to the treatment groups, independently examined the histological samples.

Results: Macroscopically, no significant differences were observed between the two groups in terms of scarring, synechiae, or granulation tissue formation at the posterior commissure. However, the mitomycin-C group demonstrated a relatively milder tissue response. Microscopic analysis revealed grade 3 collagen deposition in one rabbit and grade 1 in two rabbits from the epirubicin group. In comparison, the mitomycin-C group showed grade 1 deposition in two rabbits and grade 2 in another two. The average fibroblast count was 83.3 in the epirubicin group versus 59 in the mitomycin-C group.

Conclusions: Although this pioneering study does not provide conclusive evidence that epirubicin is as effective as or superior to mitomycin-C in laryngology, it highlights epirubicin's potential as a promising candidate for further investigation in the treatment of laryngeal conditions.

表柔比星和丝裂霉素- c具有相似的作用机制,均通过抑制DNA和蛋白质合成而表现出抗增殖作用。虽然丝裂霉素- c在喉科的疗效已经得到了很好的证实,但本研究旨在探讨表柔比星是否能在该领域产生类似的临床结果。材料与方法:选取10只家兔进行实验研究。使用耳甲探针在后连合处造成热损伤。损伤后,一组给予丝裂霉素c治疗,另一组给予表柔比星治疗。治疗6周后,对家兔实施安乐死,并进行宏观和微观评估,以评估狭窄、瘢痕、肉芽组织、坏死和溃疡。两名病理学家,对治疗组不知情,独立检查组织学样本。结果:从宏观上看,两组在后连关节处瘢痕、粘连或肉芽组织形成方面无显著差异。然而,丝裂霉素- c组表现出相对温和的组织反应。显微镜分析显示表阿霉素组1只兔胶原沉积3级,2只兔胶原沉积1级。丝裂霉素- c组2只家兔呈1级沉积,2只家兔呈2级沉积。表柔比星组的平均成纤维细胞计数为83.3,丝裂霉素- c组为59。结论:虽然这项开创性的研究并没有提供结论性的证据表明表柔比星在喉科与丝裂霉素c一样有效或优于丝裂霉素c,但它强调了表柔比星作为喉部疾病治疗的有前途的候选药物的潜力。
{"title":"Can Epirubicin Be Used in Laryngology Practice Like Mitomycin? An Experimental and Pioneering Study.","authors":"Erdem Koroglu, Selahattin Genc, Serdar Baser, Ferit Bayakır, Ahmet Tugrul Eruyar, Busra Yaprak Bayrak","doi":"10.22038/ijorl.2025.87024.3938","DOIUrl":"10.22038/ijorl.2025.87024.3938","url":null,"abstract":"<p><strong>Introduction: </strong>Epirubicin and mitomycin-C share similar mechanisms of action, with both exhibiting antiproliferative effects by inhibiting DNA and protein synthesis. While the efficacy of mitomycin-C in laryngology is well established, this study aims to investigate whether epirubicin can produce comparable clinical outcomes in this field.</p><p><strong>Materials and methods: </strong>Ten rabbits were included in this experimental study. A thermal injury was created at the posterior commissure using a conchal probe. Following the injury, one group was treated with mitomycin-C, while the other received epirubicin. After a six-week post-treatment period, the rabbits were euthanized, and both macroscopic and microscopic evaluations were performed to assess stenosis, scarring, granulation tissue, necrosis, and ulceration. Two pathologists, blinded to the treatment groups, independently examined the histological samples.</p><p><strong>Results: </strong>Macroscopically, no significant differences were observed between the two groups in terms of scarring, synechiae, or granulation tissue formation at the posterior commissure. However, the mitomycin-C group demonstrated a relatively milder tissue response. Microscopic analysis revealed grade 3 collagen deposition in one rabbit and grade 1 in two rabbits from the epirubicin group. In comparison, the mitomycin-C group showed grade 1 deposition in two rabbits and grade 2 in another two. The average fibroblast count was 83.3 in the epirubicin group versus 59 in the mitomycin-C group.</p><p><strong>Conclusions: </strong>Although this pioneering study does not provide conclusive evidence that epirubicin is as effective as or superior to mitomycin-C in laryngology, it highlights epirubicin's potential as a promising candidate for further investigation in the treatment of laryngeal conditions.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 5","pages":"247-252"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Coenzyme Q10 on Tinnitus Severity and Sleep Quality in Patients with Presbycusis. 辅酶Q10对老年性耳鸣患者耳鸣严重程度及睡眠质量的影响。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2024.79602.3681
Rohollah Abbasi, Faranak Emami, Saeid Atighechi, Zahra Sadeghi

Introduction: Tinnitus is one of the symptoms of presbycusis that affects patients' sleep and social life. This study aimed to determine the effect of coenzyme Q10 (CoQ10) on treating tinnitus due to presbycusis.

Materials and methods: In this double-blind, randomized clinical trial, 50 patients with tinnitus due to presbycusis were randomly divided into groups A and B, with 25 patients in each group. In addition to routine treatments, group A received 100 mg of CoQ10 daily, while group B received a placebo. Both groups were evaluated for tinnitus severity, loudness of tinnitus, quality of life, and sleep disturbance before and 6 weeks after starting the treatment.

Results: In the intervention and control groups, the mean changes in score compared to before the treatment were as follows: quality of life (3.1 ± 1.67) and (1.28 ± 0.76) (P = 0.298), sleep disorder (-7.60 ± 1.38) and (-1.0 ± 8.55) (P<0.001), tinnitus disability (-17.2 ± 52.93) and (-4.56 ± 1.37) (P<0.001), tinnitus loudness of right ear (-1.68 ± 0.41) and (-0.95 ± 0.23) (P=0.11) and left ear (-2.2 ± 0.35) and (-0.54 ± 0.21) (P<0.001).

Conclusion: This study indicated that adding CoQ10 to the routine regimen for patients with tinnitus due to presbycusis significantly decreases tinnitus disability, improves sleep disturbance, and reduces tinnitus loudness. However, more studies should be conducted in this regard.

耳鸣是老年性耳聋的症状之一,影响患者的睡眠和社交生活。本研究旨在探讨辅酶Q10 (CoQ10)对老年性耳鸣的治疗作用。材料与方法:将50例老年性耳鸣患者随机分为A组和B组,每组25例。除常规治疗外,A组每天服用100毫克辅酶q10,而B组服用安慰剂。两组在治疗前和治疗后6周评估耳鸣严重程度、耳鸣响度、生活质量和睡眠障碍。结果:干预组和对照组与治疗前比较,生活质量(3.1±1.67)分和(1.28±0.76)分(P = 0.298)、睡眠障碍(-7.60±1.38)分和(-1.0±8.55)分的平均变化(P = 0.298)、睡眠障碍(-7.60±1.38)分和睡眠障碍(-1.0±8.55)分。结论:本研究提示,在老年性耳鸣患者常规治疗方案中添加辅酶q10可显著降低耳鸣残疾,改善睡眠障碍,降低耳鸣响度。但是,在这方面还需要进行更多的研究。
{"title":"The Effect of Coenzyme Q10 on Tinnitus Severity and Sleep Quality in Patients with Presbycusis.","authors":"Rohollah Abbasi, Faranak Emami, Saeid Atighechi, Zahra Sadeghi","doi":"10.22038/ijorl.2024.79602.3681","DOIUrl":"10.22038/ijorl.2024.79602.3681","url":null,"abstract":"<p><strong>Introduction: </strong>Tinnitus is one of the symptoms of presbycusis that affects patients' sleep and social life. This study aimed to determine the effect of coenzyme Q10 (CoQ10) on treating tinnitus due to presbycusis.</p><p><strong>Materials and methods: </strong>In this double-blind, randomized clinical trial, 50 patients with tinnitus due to presbycusis were randomly divided into groups A and B, with 25 patients in each group. In addition to routine treatments, group A received 100 mg of CoQ10 daily, while group B received a placebo. Both groups were evaluated for tinnitus severity, loudness of tinnitus, quality of life, and sleep disturbance before and 6 weeks after starting the treatment.</p><p><strong>Results: </strong>In the intervention and control groups, the mean changes in score compared to before the treatment were as follows: quality of life (3.1 ± 1.67) and (1.28 ± 0.76) (P = 0.298), sleep disorder (-7.60 ± 1.38) and (-1.0 ± 8.55) (P<0.001), tinnitus disability (-17.2 ± 52.93) and (-4.56 ± 1.37) (P<0.001), tinnitus loudness of right ear (-1.68 ± 0.41) and (-0.95 ± 0.23) (P=0.11) and left ear (-2.2 ± 0.35) and (-0.54 ± 0.21) (P<0.001).</p><p><strong>Conclusion: </strong>This study indicated that adding CoQ10 to the routine regimen for patients with tinnitus due to presbycusis significantly decreases tinnitus disability, improves sleep disturbance, and reduces tinnitus loudness. However, more studies should be conducted in this regard.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 1","pages":"33-39"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Role of Inflammatory Markers in Predicting Central Lymph Node Metastasis in Papillary Thyroid Carcinoma. 评估炎症标志物在预测甲状腺乳头状癌中央淋巴结转移中的作用。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.84332.3840
Ebrahim Farashi, Sajjad Ranjbar, Sahand Eslami, Nikzad Shahidi, Seyed Ziaeddin Rasihashemi

Introduction: The current study sought to assess the predictive value of inflammatory markers, namely the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), in relation to central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC).

Materials and methods: A total of 79 participants with confirmed PTC diagnosis following surgery were included in the study. Demographic data, clinical characteristics, and laboratory variables were collected. CLNM was evaluated based on pathological findings. NLR and PLR were calculated to assess their associations with clinicopathological features and metastasis.

Results: The study included 26 males (25.9%) and 53 females (74.1%), with a mean age of 42.26 years (range 15-74). Significant findings included a higher incidence of CLNM in males (p=0.047) and larger tumor sizes in patients with CLNM (p=0.047). Tumor multifocality was also more common in the CLNM group (62.5% vs. 28.9%, p=0.003). Although no significant relationship was found between the inflammatory markers NLR, PLR, and CLNM, a meaningful association was observed between PLR and age in patients with CLNM (r= 0.414, p=0.011).

Conclusion: This study demonstrates significant associations between clinicopathological features and CLNM in PTC. Male gender, larger tumor size, and multifocality correlated with higher CLNM rates. While inflammatory markers such as NLR and PLR did not show significant differences, PLR's positive correlation with age in CLNM patients suggests potential prognostic value, warranting further investigation.

本研究旨在评估炎症标志物,即血小板与淋巴细胞比值(PLR)和中性粒细胞与淋巴细胞比值(NLR)在甲状腺乳头状癌(PTC)患者中与中央淋巴结转移(CLNM)相关的预测价值。材料与方法:共纳入79例术后确诊为PTC的患者。收集了人口统计资料、临床特征和实验室变量。根据病理结果对CLNM进行评估。计算NLR和PLR以评估其与临床病理特征和转移的关系。结果:男性26例(25.9%),女性53例(74.1%),平均年龄42.26岁(15 ~ 74岁)。显著发现包括男性CLNM发病率较高(p=0.047), CLNM患者肿瘤体积较大(p=0.047)。肿瘤多灶性在CLNM组中也更为常见(62.5%比28.9%,p=0.003)。虽然炎症标志物NLR、PLR和CLNM之间没有明显的关系,但CLNM患者的PLR和年龄之间有显著的相关性(r= 0.414, p=0.011)。结论:本研究显示PTC的临床病理特征与CLNM有显著相关性。男性、较大的肿瘤大小和多灶性与较高的CLNM发生率相关。虽然炎症标志物如NLR和PLR没有显示出显著差异,但CLNM患者PLR与年龄的正相关提示潜在的预后价值,值得进一步研究。
{"title":"Assessing the Role of Inflammatory Markers in Predicting Central Lymph Node Metastasis in Papillary Thyroid Carcinoma.","authors":"Ebrahim Farashi, Sajjad Ranjbar, Sahand Eslami, Nikzad Shahidi, Seyed Ziaeddin Rasihashemi","doi":"10.22038/ijorl.2025.84332.3840","DOIUrl":"10.22038/ijorl.2025.84332.3840","url":null,"abstract":"<p><strong>Introduction: </strong>The current study sought to assess the predictive value of inflammatory markers, namely the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), in relation to central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC).</p><p><strong>Materials and methods: </strong>A total of 79 participants with confirmed PTC diagnosis following surgery were included in the study. Demographic data, clinical characteristics, and laboratory variables were collected. CLNM was evaluated based on pathological findings. NLR and PLR were calculated to assess their associations with clinicopathological features and metastasis.</p><p><strong>Results: </strong>The study included 26 males (25.9%) and 53 females (74.1%), with a mean age of 42.26 years (range 15-74). Significant findings included a higher incidence of CLNM in males (<i>p</i>=0.047) and larger tumor sizes in patients with CLNM (<i>p</i>=0.047). Tumor multifocality was also more common in the CLNM group (62.5% vs. 28.9%, <i>p</i>=0.003). Although no significant relationship was found between the inflammatory markers NLR, PLR, and CLNM, a meaningful association was observed between PLR and age in patients with CLNM (<i>r</i>= 0.414, <i>p</i>=0.011).</p><p><strong>Conclusion: </strong>This study demonstrates significant associations between clinicopathological features and CLNM in PTC. Male gender, larger tumor size, and multifocality correlated with higher CLNM rates. While inflammatory markers such as NLR and PLR did not show significant differences, PLR's positive correlation with age in CLNM patients suggests potential prognostic value, warranting further investigation.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 3","pages":"135-141"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Oral Preoperative Clonidine with Infusion of Intraoperative Labetalol on Bleeding during Tympanoplasty Surgery. 术前口服可乐定与术中输注拉贝他洛尔治疗鼓室成形术出血的比较。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.78101.3626
Mohamad Reza Afzalzadeh, Mostafa Mahdavi, Saleheh Asghari, Maryam Emadzadeh

Introduction: Surgical bleeding is one of the most critical complications in various surgical procedures. In middle ear surgery, managing bleeding is a significant challenge for anesthesiologists because even minor bleeding can obstruct the surgeon's vision and prolong the surgery. Our objective is to compare the impact of preoperative oral clonidine versus labetalol infusion on bleeding volume during tympanoplasty surgery.

Materials and methods: In this double-blind randomized controlled trial, tympanoplasty candidates were randomly assigned to three groups: the clonidine group (received 300 micrograms of clonidine tablets one hour before surgery with normal saline infusion during the operation), the control group (given a placebo tablet one hour before surgery with normal saline infusion during surgery), and the labetalol group (administered a placebo tablet one hour before surgery with labetalol infusion at a rate of 0.2 mg/kg of body weight per hour during surgery). We then evaluated the extent of intraoperative bleeding, systolic and diastolic blood pressure, mean arterial pressure, and heart rate at various time points until the end of the surgery.

Results: Clonidine and labetalol were effective in reducing intraoperative bleeding compared to the control group. Grade 2 bleeding (minimal bleeding requiring intermittent suction) was the highest grade observed across all three groups and was consistently noted in all patients. Clonidine demonstrated greater efficiency in reducing systolic and diastolic blood pressure, mean arterial pressure, and heart rate compared to both labetalol and the control group.

Conclusion: Premedication with clonidine or labetalol is associated with reduced intraoperative bleeding, improved surgical field visibility, and shorter duration of tympanoplasty procedures. This may potentially lead to increased satisfaction and success rates of the operation.

手术出血是各种外科手术中最严重的并发症之一。在中耳手术中,处理出血是麻醉师面临的一个重大挑战,因为即使是轻微的出血也会阻碍外科医生的视力并延长手术时间。我们的目的是比较术前口服可乐定与拉贝他洛尔输注对鼓室成形术中出血量的影响。材料和方法:在本双盲随机对照试验中,鼓室成形术候选人随机分为三组:可乐定组(术前1小时给予可乐定片300微克,术中灌注生理盐水)、对照组(术前1小时给予安慰剂片,术中灌注生理盐水)、拉贝他洛尔组(术前1小时给予安慰剂片,术中以0.2 mg/kg体重/小时的速度灌注拉贝他洛尔)。然后,我们评估术中出血的程度,收缩压和舒张压,平均动脉压和心率在不同的时间点,直到手术结束。结果:与对照组相比,可乐定和拉贝他洛尔能有效减少术中出血。2级出血(需要间歇抽吸的少量出血)是所有三组中观察到的最高级别,并且在所有患者中都一致注意到。与拉贝他洛尔和对照组相比,可乐定在降低收缩压和舒张压、平均动脉压和心率方面表现出更大的效率。结论:术前应用可乐定或拉贝他洛尔可减少术中出血,提高手术视野可见度,缩短鼓室成形术时间。这可能会潜在地提高手术的满意度和成功率。
{"title":"Comparison of Oral Preoperative Clonidine with Infusion of Intraoperative Labetalol on Bleeding during Tympanoplasty Surgery.","authors":"Mohamad Reza Afzalzadeh, Mostafa Mahdavi, Saleheh Asghari, Maryam Emadzadeh","doi":"10.22038/ijorl.2025.78101.3626","DOIUrl":"10.22038/ijorl.2025.78101.3626","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical bleeding is one of the most critical complications in various surgical procedures. In middle ear surgery, managing bleeding is a significant challenge for anesthesiologists because even minor bleeding can obstruct the surgeon's vision and prolong the surgery. Our objective is to compare the impact of preoperative oral clonidine versus labetalol infusion on bleeding volume during tympanoplasty surgery.</p><p><strong>Materials and methods: </strong>In this double-blind randomized controlled trial, tympanoplasty candidates were randomly assigned to three groups: the clonidine group (received 300 micrograms of clonidine tablets one hour before surgery with normal saline infusion during the operation), the control group (given a placebo tablet one hour before surgery with normal saline infusion during surgery), and the labetalol group (administered a placebo tablet one hour before surgery with labetalol infusion at a rate of 0.2 mg/kg of body weight per hour during surgery). We then evaluated the extent of intraoperative bleeding, systolic and diastolic blood pressure, mean arterial pressure, and heart rate at various time points until the end of the surgery.</p><p><strong>Results: </strong>Clonidine and labetalol were effective in reducing intraoperative bleeding compared to the control group. Grade 2 bleeding (minimal bleeding requiring intermittent suction) was the highest grade observed across all three groups and was consistently noted in all patients. Clonidine demonstrated greater efficiency in reducing systolic and diastolic blood pressure, mean arterial pressure, and heart rate compared to both labetalol and the control group.</p><p><strong>Conclusion: </strong>Premedication with clonidine or labetalol is associated with reduced intraoperative bleeding, improved surgical field visibility, and shorter duration of tympanoplasty procedures. This may potentially lead to increased satisfaction and success rates of the operation.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 3","pages":"105-113"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kikuchi-Fujimoto Disease: A Rare Condition Mimicking Sepsis. 菊池-藤本病:一种类似败血症的罕见疾病。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.82006.3754
Sethu Thakachy Subha, Naseeha Roslan Ainur, Mohd Ali Razana

Introduction: Kikuchi-Fujimoto disease is a self-limited disease which is also known as histiocytic necrotizing lymphadenitis. The Kikuchi-Fujimoto disease is a rare cause of cervical lymphadenopathy, with or without systemic signs, such as fever, leukopenia, and skin rashes.

Case report: We presented a case of Kikuchi-Fujimoto disease in a 29-year-old female mimicking sepsis after a COVID-19 infection. Clinical examination revealed stable vitals and multiple diffuse non-tender bilateral cervical and axillary lymph adenopathy with hepatosplenomegaly. The patient's blood parameters showed leukopenia, raised erythrocyte sedimentation rate, lactate dehydrogenase, microcytic hypochromic anemia with normal renal and liver function tests. The patient was treated with broad spectrum intravenous antibiotics and subcutaneous neupogen with a clinical suspicion of sepsis. The patient then underwent a CT scan which validated the clinical findings. Although the fever subsided, a persistent cervical lymphadenopathy was observed and the biopsy confirmed it to be necrotising lymph adenitis secondary to Kikuchi-Fujimoto disease. This patient has been regularly monitored and has shown resolution of cervical lymphadenopathy.

Conclusion: Clinicians should suspect Kikuchi-Fujimoto disease when patients present with persistent cervical lymphadenopathy unresponsive to initial medical treatment. Lymph node biopsy should be undertaken to rule out Kikuchi-Fujimoto disease and prevent these patients from extensive diagnostic procedures and inappropriate treatment modalities.

简介:菊池-藤本病是一种自限性疾病,又称组织细胞坏死性淋巴结炎。菊池-藤本病是一种罕见的颈部淋巴结病,有或无全身体征,如发热、白细胞减少和皮疹。病例报告:我们报告了一例29岁女性在COVID-19感染后模仿败血症的菊池-藤本病。临床检查显示生命体征稳定,双侧颈部及腋窝多发弥漫性无压痛性淋巴结肿大伴肝脾肿大。患者血液指标为白细胞减少、红细胞沉降、乳酸脱氢酶升高、小细胞性低色素贫血,肾功能、肝功能检查正常。患者经广谱静脉注射抗生素和皮下吸氧治疗,临床怀疑为败血症。患者随后接受了CT扫描,证实了临床结果。虽然发烧消退,但观察到持续的颈部淋巴结病,活检证实为继发于菊池-藤本病的坏死性淋巴腺炎。该患者已定期监测,并已显示颈淋巴肿大的解决。结论:临床医生应怀疑菊池-藤本病,当患者表现为持续颈淋巴肿大,对最初的药物治疗无反应。应进行淋巴结活检以排除菊池-藤本病,并防止这些患者进行广泛的诊断程序和不适当的治疗方式。
{"title":"Kikuchi-Fujimoto Disease: A Rare Condition Mimicking Sepsis.","authors":"Sethu Thakachy Subha, Naseeha Roslan Ainur, Mohd Ali Razana","doi":"10.22038/ijorl.2025.82006.3754","DOIUrl":"10.22038/ijorl.2025.82006.3754","url":null,"abstract":"<p><strong>Introduction: </strong>Kikuchi-Fujimoto disease is a self-limited disease which is also known as histiocytic necrotizing lymphadenitis. The Kikuchi-Fujimoto disease is a rare cause of cervical lymphadenopathy, with or without systemic signs, such as fever, leukopenia, and skin rashes.</p><p><strong>Case report: </strong>We presented a case of Kikuchi-Fujimoto disease in a 29-year-old female mimicking sepsis after a COVID-19 infection. Clinical examination revealed stable vitals and multiple diffuse non-tender bilateral cervical and axillary lymph adenopathy with hepatosplenomegaly. The patient's blood parameters showed leukopenia, raised erythrocyte sedimentation rate, lactate dehydrogenase, microcytic hypochromic anemia with normal renal and liver function tests. The patient was treated with broad spectrum intravenous antibiotics and subcutaneous neupogen with a clinical suspicion of sepsis. The patient then underwent a CT scan which validated the clinical findings. Although the fever subsided, a persistent cervical lymphadenopathy was observed and the biopsy confirmed it to be necrotising lymph adenitis secondary to Kikuchi-Fujimoto disease. This patient has been regularly monitored and has shown resolution of cervical lymphadenopathy.</p><p><strong>Conclusion: </strong>Clinicians should suspect Kikuchi-Fujimoto disease when patients present with persistent cervical lymphadenopathy unresponsive to initial medical treatment. Lymph node biopsy should be undertaken to rule out Kikuchi-Fujimoto disease and prevent these patients from extensive diagnostic procedures and inappropriate treatment modalities.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 3","pages":"161-164"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Transcanal Type 1 Tympanoplasty with Cartilage Perichondrium Graft; A Prospective Study. 经鼻内镜下软骨软骨膜移植1型鼓室成形术前瞻性研究。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.83887.3826
Parth Makwana, Viral Prajapati, Vivek Makadiya

Introduction: Recently use of endoscopes for ear surgeries is being popular among the surgeons as it gives a wide view of the middle ear. Also, tympanoplasty by transcanal approach can be done as a day care procedure and so it reduces the cost of hospitalization. The study was aimed to evaluate the results of type 1 tympanoplasty done by endoscopic transcanal approach with cartilage perichondrium graft, in relation to successful graft take-up rate and improvement in hearing.

Materials and methods: Total 50 patients were included in the study and all of them underwent type 1 tympanoplasty by endoscopic transcanal approach. Tragal cartilage with its attached perichondrium on one side facing laterally was placed as graft lateral to handle of malleus with v shaped notch at 12 o clock by underlay technique in all the cases. Patients were called for regular follow-up, and they were observed for successful graft take-up and improvement in hearing at 3 months after procedure.

Results: Out of 50 cases complete closure was achieved in 46 cases which makes a success rate of 92%. The average improvement in hearing of 15.3 dB was noted.

Conclusion: Endoscopic Transcanal approach with cartilage-perichondrium graft for tympanoplasty (type 1) is effective in terms of successful graft take-up rate and improvement in hearing, very cost effective, faster in terms of surgical time, and has less postoperative morbidity so gives better quality of life to the patient.

导读:近年来,内窥镜在耳外科手术中越来越受外科医生的欢迎,因为它可以提供中耳的广阔视野。此外,经鼻入路的鼓室成形术可以作为日间护理手术,因此它减少了住院费用。本研究旨在评估经鼻内窥镜下经鼻道软骨软骨膜移植1型鼓室成形术的结果,与移植成功率和听力改善的关系。材料与方法:本研究共纳入50例患者,均采用经鼻内镜入路行1型鼓室成形术。所有病例均采用下垫法将侧耳屏软骨及其所附软骨膜侧向放置于外踝柄外侧,并在12°处形成v形切口。患者被要求定期随访,并在手术后3个月观察移植物的成功使用和听力的改善。结果:50例患者中46例完全闭合,成功率92%。平均听力改善15.3 dB。结论:内镜下经鼻入路软骨-软骨膜移植行鼓室成形术(1型),植片成功率高,听力改善,成本效益高,手术时间短,术后发病率低,患者生活质量好。
{"title":"Endoscopic Transcanal Type 1 Tympanoplasty with Cartilage Perichondrium Graft; A Prospective Study.","authors":"Parth Makwana, Viral Prajapati, Vivek Makadiya","doi":"10.22038/ijorl.2025.83887.3826","DOIUrl":"10.22038/ijorl.2025.83887.3826","url":null,"abstract":"<p><strong>Introduction: </strong>Recently use of endoscopes for ear surgeries is being popular among the surgeons as it gives a wide view of the middle ear. Also, tympanoplasty by transcanal approach can be done as a day care procedure and so it reduces the cost of hospitalization. The study was aimed to evaluate the results of type 1 tympanoplasty done by endoscopic transcanal approach with cartilage perichondrium graft, in relation to successful graft take-up rate and improvement in hearing.</p><p><strong>Materials and methods: </strong>Total 50 patients were included in the study and all of them underwent type 1 tympanoplasty by endoscopic transcanal approach. Tragal cartilage with its attached perichondrium on one side facing laterally was placed as graft lateral to handle of malleus with v shaped notch at 12 o clock by underlay technique in all the cases. Patients were called for regular follow-up, and they were observed for successful graft take-up and improvement in hearing at 3 months after procedure.</p><p><strong>Results: </strong>Out of 50 cases complete closure was achieved in 46 cases which makes a success rate of 92%. The average improvement in hearing of 15.3 dB was noted.</p><p><strong>Conclusion: </strong>Endoscopic Transcanal approach with cartilage-perichondrium graft for tympanoplasty (type 1) is effective in terms of successful graft take-up rate and improvement in hearing, very cost effective, faster in terms of surgical time, and has less postoperative morbidity so gives better quality of life to the patient.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 5","pages":"261-266"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes of the U-Linear Split Thickness Skin Graft Technique for Reconstruction for Ear Canal Stenosis. u型线形裂厚皮肤移植技术用于耳道狭窄再造术的临床效果。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22038/ijorl.2025.87421.3932
Kanokkarn Mahawerawat, Pornthep Kasemsiri, Chonthicha Chit-Uea-Ophat

Introduction: Canaloplasty is challenging because of the high rate of postoperative restenosis. The aim of this study was to evaluate the outcomes of using a U-Linear split-thickness skin graft (U-Linear STSG), a novel modified graft placement technique for canaloplasty.

Materials and methods: A retrospective cross-sectional study was conducted on patients who underwent canaloplasty between January 2013 and December 2023. The medical records of external auditory canal stenosis patients who underwent canaloplasty were reviewed. The data collected included patient demographics, surgical approaches, postoperative outcomes, and audiometric findings. The outcomes of reconstruction for ear canal stenosis using a U-Linear STSG were compared with those using a reconstructed local flap. Statistical analyses included chi-square tests for categorical data and independent t tests for continuous data.

Results: Thirty-six patients with external auditory canal stenosis underwent reconstruction; 17 patients underwent reconstruction with a U-Linear STSG, and 19 patients underwent reconstruction with a local flap. A review of the clinical outcomes revealed that postoperative restenosis was significantly less common in the U-Linear STSG group than in the local flap group (p < 0.05). In terms of audiometry, the postoperative air‒bone gap in the U-STSG group was slightly greater than that in the local group. No serious complications were observed in either group.

Conclusion: A U-Linear STSG can be simply and feasibly applied in reconstruction for ear canal stenosis, with no major complications.

导言:由于术后再狭窄率高,导管成形术具有挑战性。本研究的目的是评估使用U-Linear裂厚皮肤移植物(U-Linear STSG)的结果,这是一种用于管道成形术的新型改良移植物放置技术。材料与方法:对2013年1月至2023年12月间行导管成形术的患者进行回顾性横断面研究。回顾外耳道狭窄患者行外耳道成形术的医疗记录。收集的数据包括患者人口统计学、手术入路、术后结果和听力测量结果。我们比较了使用U-Linear STSG重建耳道狭窄和使用重建局部皮瓣的结果。统计分析包括分类资料的卡方检验和连续资料的独立t检验。结果:36例外耳道狭窄患者行重建术;17例患者行U-Linear STSG重建,19例患者行局部皮瓣重建。临床结果回顾显示,U-Linear STSG组术后再狭窄发生率明显低于局部皮瓣组(p < 0.05)。在听力学方面,U-STSG组术后气骨间隙略大于局部组。两组均未见严重并发症。结论:U-Linear STSG用于耳道狭窄再造术简单可行,无重大并发症。
{"title":"Clinical Outcomes of the U-Linear Split Thickness Skin Graft Technique for Reconstruction for Ear Canal Stenosis.","authors":"Kanokkarn Mahawerawat, Pornthep Kasemsiri, Chonthicha Chit-Uea-Ophat","doi":"10.22038/ijorl.2025.87421.3932","DOIUrl":"10.22038/ijorl.2025.87421.3932","url":null,"abstract":"<p><strong>Introduction: </strong>Canaloplasty is challenging because of the high rate of postoperative restenosis. The aim of this study was to evaluate the outcomes of using a U-Linear split-thickness skin graft (U-Linear STSG), a novel modified graft placement technique for canaloplasty.</p><p><strong>Materials and methods: </strong>A retrospective cross-sectional study was conducted on patients who underwent canaloplasty between January 2013 and December 2023. The medical records of external auditory canal stenosis patients who underwent canaloplasty were reviewed. The data collected included patient demographics, surgical approaches, postoperative outcomes, and audiometric findings. The outcomes of reconstruction for ear canal stenosis using a U-Linear STSG were compared with those using a reconstructed local flap. Statistical analyses included chi-square tests for categorical data and independent t tests for continuous data.</p><p><strong>Results: </strong>Thirty-six patients with external auditory canal stenosis underwent reconstruction; 17 patients underwent reconstruction with a U-Linear STSG, and 19 patients underwent reconstruction with a local flap. A review of the clinical outcomes revealed that postoperative restenosis was significantly less common in the U-Linear STSG group than in the local flap group (p < 0.05). In terms of audiometry, the postoperative air‒bone gap in the U-STSG group was slightly greater than that in the local group. No serious complications were observed in either group.</p><p><strong>Conclusion: </strong>A U-Linear STSG can be simply and feasibly applied in reconstruction for ear canal stenosis, with no major complications.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"37 6","pages":"335-340"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Otorhinolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1